Symbiotec Pharmalab is looking to raise Rs 1,757 crore through the IPO.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
As IndiGo, Air India scramble for pilots, fresh headwinds hit hard
When a CFO resigns, is ‘personal reasons’ explanation enough?
FCNR (B) scheme garners USD65 bn, but why isn't the rupee gaining?
ET Prime special: Bigger, Better or Both? Understanding business to figure out the mystery: Power Grid Corp – Part 1
US bond yield: Will it become a new pain point?
Bigger or Better: BEL’s biggest shareholder is also its biggest customer – and its rule-maker. Final part
Source: Read the original article on economictimes.indiatimes.com
Additional coverage from economictimes.indiatimes.com:
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
As IndiGo, Air India scramble for pilots, fresh headwinds hit hard
When a CFO resigns, is ‘personal reasons’ explanation enough?
FCNR (B) scheme garners USD65 bn, but why isn't the rupee gaining?
ET Prime special: Bigger, Better or Both? Understanding business to figure out the mystery: Power Grid Corp – Part 1
US bond yield: Will it become a new pain point?
Bigger or Better: BEL’s biggest shareholder is also its biggest customer – and its rule-maker. Final part
🟢 PROS / ADVANTAGES
- FCNR (B) scheme garners USD65 bn, but why isn't the rupee gaining?
🔴 CONS / RISKS
- Heightened market volatility and varying analyst expectations introduce near-term execution risks.
- Implementation dependencies and compliance checkpoints may slow down the projected business timeline.
